当前位置:首页 - 行情中心 - 柳药集团(603368) - 财务分析 - 现金流量表

柳药集团

(603368)

  

流通市值:68.04亿  总市值:68.33亿
流通股本:3.97亿   总股本:3.99亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金5,296,484,745.5725,026,615,293.916,159,907,085.6811,737,092,223.16
收到的税费返还--291,838.22273,591.11
收到其他与经营活动有关的现金178,925,289.4305,162,619.73255,661,299.11122,639,259.79
经营活动现金流入的平衡项目0000
经营活动现金流入小计5,475,410,034.9725,331,777,913.6316,415,860,223.0111,860,005,074.06
购买商品、接受劳务支付的现金5,448,862,701.722,573,212,702.7314,870,797,858.5410,916,272,073.14
支付给职工以及为职工支付的现金162,304,542.55531,066,520.07411,247,234.26283,319,681.81
支付的各项税费119,460,464.86574,548,061.41366,003,846.23271,493,484.46
支付其他与经营活动有关的现金262,374,109.38814,437,752.31644,831,653.77339,257,356.63
经营活动现金流出的平衡项目0000
经营活动现金流出小计5,993,001,818.4924,493,265,036.5216,292,880,592.811,810,342,596.04
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-517,591,783.52838,512,877.11122,979,630.2149,662,478.02
二、投资活动产生的现金流量:
收回投资收到的现金50,322,3001,700,000--
取得投资收益收到的现金22,086,424.6518,561,979.413,860,749.974,346,726.4
处置固定资产、无形资产和其他长期资产收回的现金净额34,123.55128,679.04219,963.24395,546.7
处置子公司及其他营业单位收到的现金净额--54,665.93-
收到的其他与投资活动有关的现金250,000,0001,294,000,000239,074,400104,000,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计322,442,848.21,314,390,658.45243,209,779.14108,742,273.1
购建固定资产、无形资产和其他长期资产支付的现金49,980,946.06147,873,427.02100,376,102.9259,325,202.88
投资支付的现金240,158,537.8564,859,30014,537,00014,537,000
支付其他与投资活动有关的现金-1,244,000,000233,854,7934,000,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计290,139,483.911,456,732,727.02348,767,895.9277,862,202.88
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额32,303,364.29-142,342,068.57-105,558,116.7830,880,070.22
三、筹资活动产生的现金流量:
吸收投资收到的现金-690,999,995695,749,549695,299,549
其中:子公司吸收少数股东投资收到的现金--695,749,549695,299,549
取得借款收到的现金1,076,979,560.194,155,329,571.173,305,940,796.442,183,440,796.44
收到其他与筹资活动有关的现金409,877,484.632,106,736,830.91,259,795,352.85396,484,099.9
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,486,857,044.826,953,066,397.075,261,485,698.293,275,224,445.34
偿还债务支付的现金723,790,796.444,330,254,589.473,087,975,385.971,670,266,528.62
分配股利、利润或偿付利息支付的现金54,301,995.88413,967,265.92384,907,759.6345,956,639.25
其中:子公司支付给少数股东的股利、利润1,617,0001,617,0001,617,0001,617,000
支付其他与筹资活动有关的现金1,496,567,100.552,155,403,519.352,572,756,155.581,692,579,185.03
筹资活动现金流出平衡项目0000
筹资活动现金流出小计2,274,659,892.876,899,625,374.746,045,639,301.153,708,802,352.9
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-787,802,848.0553,441,022.33-784,153,602.86-433,577,907.56
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,273,091,267.28749,611,830.87-766,732,089.43-353,035,359.32
加:期初现金及现金等价物余额3,398,494,775.132,648,949,233.352,648,949,233.352,648,949,233.35
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,125,403,507.853,398,561,064.221,882,217,143.922,295,913,874.03
补充资料:
净利润-867,534,387.56-490,773,357.18
固定资产和投资性房地产折旧-81,355,080.98-40,825,051.69
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-81,355,080.98-40,825,051.69
无形资产摊销-23,168,139.48-12,392,012.44
长期待摊费用摊销-26,026,328.53-13,128,315.19
处置固定资产、无形资产和其他长期资产的损失--3,025,141.41--735,970.29
固定资产报废损失-365,832.79-34,611.05
财务费用-225,129,194.47-135,671,089.43
投资损失-95,285.99-45,066.81
递延所得税--6,786,185.58--14,967,872.66
其中:递延所得税资产减少--2,755,969.65--12,828,091.08
递延所得税负债增加--4,030,215.93--2,139,781.58
存货的减少--336,179,691.69--497,382,016.24
经营性应收项目的减少--282,832,553.91--531,687,109.48
经营性应付项目的增加-112,448,977.89-295,387,903.89
其他--2,480,840.03--1,177,864.46
现金的期末余额-3,398,561,064.22-2,295,913,874.03
减:现金的期初余额-2,648,949,233.35-2,648,949,233.35
公告日期2025-04-292025-03-272024-10-302024-08-29
审计意见(境内)标准无保留意见
TOP↑